Cardiac Fibrosis: The Fibroblast Awakens

Wound repair and regeneration

Gurtner, G. C., Werner, S., Barrandon, Y., & Longaker, M. T. (2008) · Nature · doi:10.1038/nature07039 · Cited by 6,542

Heart Disease and Stroke Statistics—2015 Update: A Report From the American Heart Association

Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., de Ferranti, S., Després, J.-P., Fullerton, H. J., Howard, V. J., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000152 · Cited by 5,797

Myofibroblasts and mechano-regulation of connective tissue remodelling

Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C., & Brown, R. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm809 · Cited by 4,290

A perivascular origin for mesenchymal stem cells in multiple human organs

Crisan, M., Yap, S., Casteilla, L., Chen, C.-W., Corselli, M., Park, T. S., Andriolo, G., Sun, B., Zheng, B., Zhang, L., et al. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.07.003 · Cited by 3,991

Regulation of type I interferon responses

Ivashkiv, L. B., & Donlin, L. T. (2013) · Nature reviews. Immunology · doi:10.1038/nri3581 · Cited by 3,442

A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy

Molkentin, J. D., Lu, J., Antos, C. L., Markham, B. E., Richardson, J. A., Robbins, J. M., Grant, S. R., & Olson, E. N. (1998) · Cell · doi:10.1016/s0092-8674(00)81573-1 · Cited by 2,566

Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors

Ieda, M., Fu, J.-D., Delgado-Olguin, P., Vedantham, V., Hayashi, Y., Bruneau, B. G., & Srivastava, D. (2010) · Cell · doi:10.1016/j.cell.2010.07.002 · Cited by 2,454

TGF-β signaling and the fibrotic response

Leask, A., & Abraham, D. J. (2004) · The FASEB Journal · doi:10.1096/fj.03-1273rev · Cited by 2,319

Endothelial-to-mesenchymal transition contributes to cardiac fibrosis

Zeisberg, E. M., Tarnavski, O., Zeisberg, M., Dorfman, A. L., McMullen, J. R., Gustafsson, E., Chandraker, A. K., Yuan, X., Pu, W. T., Roberts, A. B., et al. (2007) · Nature Medicine · doi:10.1038/nm1613 · Cited by 2,251

Connecting sex differences, estrogen signaling, and microRNAs in cardiac fibrosis

Medzikovic, L., Aryan, L., & Eghbali, M. (2019) · Journal of Molecular Medicine · doi:10.1007/s00109-019-01833-6 · Cited by 69

Roles of rutin in cardiac remodeling

Siti, H. N., Jalil, J., Asmadi, A. Y., & Kamisah, Y. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.103606 · Cited by 70

Macrophage reprogramming for therapy

Bart, V. M. T., Pickering, R. J., Taylor, P. R., & Ipseiz, N. (2020) · Immunology · doi:10.1111/imm.13300 · Cited by 73

Oxidative Stress, Inflammation, and Mitochondrial Dysfunction: A Link between Obesity and Atrial Fibrillation

Balan, A. I., Halațiu, V.-B., & Scridon, A. (2024) · Antioxidants · doi:10.3390/antiox13010117 · Cited by 69

Pathophysiology and therapeutic potential of cardiac fibrosis

Hara, H., Takeda, N., & Komuro, I. (2017) · Inflammation and Regeneration · doi:10.1186/s41232-017-0046-5 · Cited by 69

GRK5 is a regulator of fibroblast activation and cardiac fibrosis

Eguchi, A., Coleman, R. C., Gresham, K. S., Gao, E., Ibetti, J., Chuprun, J. K., & Koch, W. J. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2012854118 · Cited by 68

Selective inhibition of stromal mechanosensing suppresses cardiac fibrosis

Cho, S., Rhee, S., Madl, C. M., Caudal, A., Thomas, D., Kim, H., Kojic, A., Shin, H. S., Mahajan, A., Jahng, J. W. S., et al. (2025) · Nature · doi:10.1038/s41586-025-08945-9 · Cited by 75

Cardiomyocyte ageing and cardioprotection: consensus document from the ESC working groups cell biology of the heart and myocardial function

Ruiz-Meana, M., Bou-Teen, D., Ferdinandy, P., Gyongyosi, M., Pesce, M., Perrino, C., Schulz, R., Sluijter, J. P. G., Tocchetti, C. G., Thum, T., et al. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa132 · Cited by 67

Stable Oxidative Cytosine Modifications Accumulate in Cardiac Mesenchymal Cells From Type2 Diabetes Patients

Spallotta, F., Cencioni, C., Atlante, S., Garella, D., Cocco, M., Mori, M., Mastrocola, R., Kuenne, C. T., Günther, S., Nanni, S., et al. (2017) · Circulation Research · doi:10.1161/circresaha.117.311300 · Cited by 69

Paroxetine-mediated GRK2 inhibition is a disease-modifying treatment for osteoarthritis

Carlson, E. L., Karuppagounder, V., Pinamont, W. J., Yoshioka, N. K., Ahmad, A., Schott, E. M., Bleu, H. K. L., Zuscik, M. J., Elbarbary, R. A., & Kamal, F. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.aau8491 · Cited by 67

RNA modifications in cardiovascular diseases, the potential therapeutic targets

Wu, Y., Zhan, S., Xu, Y., & Gao, X. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119565 · Cited by 69

Adverse outcome pathway of fine particulate matter leading to increased cardiovascular morbidity and mortality: An integrated perspective from toxicology and epidemiology

Yu, Y., Sun, Q., Li, T., Ren, X., Lin, L., Sun, M., Duan, J., & Sun, Z. (2022) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2022.128368 · Cited by 67

Pharmacological and Activated Fibroblast Targeting of Gβγ-GRK2 After Myocardial Ischemia Attenuates Heart Failure Progression

Travers, J. G., Kamal, F., Valiente-Alandí, Í., Nieman, M. L., Sargent, M. A., Lorenz, J. N., Molkentin, J. D., & Blaxall, B. C. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.06.049 · Cited by 67

Detection of myocardial fibrosis by speckle-tracking echocardiography: from prediction to clinical applications

Lisi, M., Cameli, M., Mandoli, G. E., Pastore, M. C., Righini, F. M., D’Ascenzi, F., Focardi, M., Rubboli, A., Mondillo, S., & Henein, M. Y. (2022) · Heart Failure Reviews · doi:10.1007/s10741-022-10214-0 · Cited by 68

Emerging molecular imaging targets and tools for myocardial fibrosis detection

Barton, A. K., Tzolos, E., Bing, R., Singh, T., Weber, W., Schwaiger, M., Varasteh, Z., Slart, R. H. J. A., Newby, D. E., & Dweck, M. R. (2022) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeac242 · Cited by 68

Myocardial Interstitial Fibrosis in Hypertensive Heart Disease: From Mechanisms to Clinical Management

González, A., López, B., Ravassa, S., José, G. S., Latasa, I., Butler, J., & Dı́ez, J. (2023) · Hypertension · doi:10.1161/hypertensionaha.123.21708 · Cited by 69

Role of Non-Myocyte Gap Junctions and Connexin Hemichannels in Cardiovascular Health and Disease: Novel Therapeutic Targets?

Johnson, R., & Camelliti, P. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030866 · Cited by 73

Dual inhibition of cathepsin G and chymase reduces myocyte death and improves cardiac remodeling after myocardial ischemia reperfusion injury

Hooshdaran, B., Kolpakov, M. A., Guo, X., Miller, S. A., Wang, T., Tilley, D. G., Rafiq, K., & Sabri, A. (2017) · Basic Research in Cardiology · doi:10.1007/s00395-017-0652-z · Cited by 64

Myofibroblasts and inflammatory cells as players of cardiac fibrosis

Kurose, H., & Mangmool, S. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0809-6 · Cited by 65

Three in a Box: Understanding Cardiomyocyte, Fibroblast, and Innate Immune Cell Interactions to Orchestrate Cardiac Repair Processes

Psarras, S., Beis, D., Nikouli, S., Tsikitis, M., & Capetanaki, Y. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00032 · Cited by 63

Roles of Biomarkers in Myocardial Fibrosis

Ding, Y., Wang, Y., Zhang, W., Jia, Q., Wang, X., Li, Y., Lv, S., & Zhang, J. (2020) · Aging and Disease · doi:10.14336/ad.2020.0604 · Cited by 67

Molecular and Cellular Mechanisms Associated with Effects of Molecular Hydrogen in Cardiovascular and Central Nervous Systems

Barančı́k, M., Kura, B., LeBaron, T. W., Bolli, R., Buday, J., & Slezák, J. (2020) · Antioxidants · doi:10.3390/antiox9121281 · Cited by 66

Central role of cardiac fibroblasts in myocardial fibrosis of diabetic cardiomyopathy

Cheng, Y., Wang, Y., Yin, R., Xu, Y., Zhang, L., Zhang, Y., Yang, L., & Zhao, D. B. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1162754 · Cited by 68

Review of the Protective Mechanism of Curcumin on Cardiovascular Disease

Yang, C., Zhu, Q., Chen, Y., Ji, K., Li, S., Wu, Q., Pan, Q., & Li, J. (2024) · Drug Design Development and Therapy · doi:10.2147/dddt.s445555 · Cited by 67

DNA methylation regulated gene expression in organ fibrosis

Zhang, X., Hu, M., Lyu, X., Li, C., Thannickal, V. J., & Sanders, Y. Y. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.05.010 · Cited by 67

Saikosaponin A Protects From Pressure Overload-Induced Cardiac Fibrosis via Inhibiting Fibroblast Activation or Endothelial Cell EndMT

Liu, Y., Gao, L., Zhao, X., Guo, S., Liu, Y., Li, R., Liang, C., Li, L., Dong, J., Li, L., et al. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.27022 · Cited by 60

A Comprehensive Analysis of the Efficacy of Resveratrol in Atherosclerotic Cardiovascular Disease, Myocardial Infarction and Heart Failure

Raj, P., Thandapilly, S. J., Wigle, J. T., Zieroth, S. R., & Netticadan, T. (2021) · Molecules · doi:10.3390/molecules26216600 · Cited by 66

Myocardial Fibroblast Activation After Acute Myocardial Infarction

Barton, A. K., Craig, N. J., Loganath, K., Joshi, S. S., Tsampasian, V., Mahendran, M., Lenell, J., Tzolos, E., Singh, T., Whittington, B., et al. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.10.103 · Cited by 69

Long non-coding RNAs in the failing heart and vasculature

Hermans-Beijnsberger, S., van Bilsen, M., & Schroen, B. L. M. (2018) · Non-coding RNA Research · doi:10.1016/j.ncrna.2018.04.002 · Cited by 63

Immune Response Mediates Cardiac Dysfunction after Traumatic Brain Injury

Zhao, Q., Yan, T., Li, L., Chopp, M., Venkat, P., Yu, Q., Li, R., Wu, R., Li, W., Lü, M., et al. (2018) · Journal of Neurotrauma · doi:10.1089/neu.2018.5766 · Cited by 64

An Improved Method of Maintaining Primary Murine Cardiac Fibroblasts in Two-Dimensional Cell Culture

Landry, N. M., Rattan, S. G., & Dixon, I. (2019) · Scientific Reports · doi:10.1038/s41598-019-49285-9 · Cited by 66

Heart failure in single right ventricle congenital heart disease: physiological and molecular considerations

Garcia, A. M., Beatty, J.-T., & Nakano, S. J. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00518.2019 · Cited by 62

The Non-Fibrillar Side of Fibrosis: Contribution of the Basement Membrane, Proteoglycans, and Glycoproteins to Myocardial Fibrosis

Chute, M., Aujla, P. K., Jana, S., & Kassiri, Z. (2019) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd6040035 · Cited by 64

Targeting Rho-associated coiled-coil forming protein kinase (ROCK) in cardiovascular fibrosis and stiffening

Yu, B., Sladojević, N., Blair, J. E., & Liao, J. K. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1712593 · Cited by 62

M2b Macrophages Regulate Cardiac Fibroblast Activation and Alleviate Cardiac Fibrosis After Reperfusion Injury

Yuan, Y., Huang, S., Wang, L., Wu, Z., Liang, M., Li, H., Lv, L., Li, W., & Wu, Z. (2020) · Circulation Journal · doi:10.1253/circj.cj-19-0959 · Cited by 60

Progress and prospect of nanotechnology for cardiac fibrosis treatment

Gaytan, S. L., Beaven, E., Gadad, S. S., & Nurunnabi, M. (2023) · Interdisciplinary medicine · doi:10.1002/inmd.20230018 · Cited by 64

MicroRNA profiling in kidney disease: Plasma versus plasma-derived exosomes

Xie, J. X., Fan, X., Drummond, C. A., Majumder, R., Xie, Y., Chen, T., Liu, L., Haller, S. T., Brewster, P. S., Dworkin, L. D., et al. (2017) · Gene · doi:10.1016/j.gene.2017.06.003 · Cited by 59

Human antigen R as a therapeutic target in pathological cardiac hypertrophy

Green, L. C., Anthony, S., Slone, S., Lanzillotta, L., Nieman, M. L., Wu, X., Robbins, N., Jones, S. M., Roy, S., Owens, A. P., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.121541 · Cited by 60

Simvastatin Attenuates Cardiac Fibrosis via Regulation of Cardiomyocyte-Derived Exosome Secretion

Kuo, H., Hsieh, C., Wang, S., Chang, C.-Y., Hung, C., Kuo, P., Liu, Y., Li, C., & Liu, P. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8060794 · Cited by 61

Targeting monocytes/macrophages in fibrosis and cancer diseases: Therapeutic approaches

Conte, E. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.108031 · Cited by 61

Cardiac fibroblast heat shock protein 47 aggravates cardiac fibrosis post myocardial ischemia–reperfusion injury by encouraging ubiquitin specific peptidase 10 dependent Smad4 deubiquitination

Xie, S., Xing, Y., Shi, W., Zhang, M., Chen, M., Fang, W., Liu, S., Zhang, T., Zeng, X., Chen, S., et al. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.07.022 · Cited by 61

IRX2 regulates angiotensin II-induced cardiac fibrosis by transcriptionally activating EGR1 in male mice

Ma, Z., Yuan, Y., Fan, D., Zhang, X., Teng, T., Song, P. K., Kong, C., Hu, C., Wei, W., & Tang, Q. (2023) · Nature Communications · doi:10.1038/s41467-023-40639-6 · Cited by 59

Fibroblasts: Diverse Cells Critical to Biomaterials Integration

Hannan, R. T., Peirce, S. M., & Barker, T. H. (2018) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.7b00244 · Cited by 59

Inhibition of microRNA‐150‐5p alleviates cardiac inflammation and fibrosis via targeting Smad7 in high glucose‐treated cardiac fibroblasts

Che, H., Wang, Y., Li, Y., Lv, J., Li, H. Z., Liu, Y., Dong, R., Sun, Y., Xu, X., Zhao, J., et al. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29386 · Cited by 59

Intermittent hypoxia mediated by TSP1 dependent on STAT3 induces cardiac fibroblast activation and cardiac fibrosis

Bao, Q., Zhang, B., Suo, Y., Liu, C., Yang, Q., Zhang, K., Yuan, M., Yuan, M., Zhang, Y., & Li, G. (2020) · eLife · doi:10.7554/elife.49923 · Cited by 59

Nicotinamide mononucleotide attenuates isoproterenol-induced cardiac fibrosis by regulating oxidative stress and Smad3 acetylation

Wu, K., Li, B., Lin, Q., Xu, W., Zuo, W., Li, J., Liu, N., Tu, T., Zhang, B., Xiao, Y., et al. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119299 · Cited by 59

Glycolysis Inhibition Alleviates Cardiac Fibrosis After Myocardial Infarction by Suppressing Cardiac Fibroblast Activation

Chen, Z.-T., Gao, Q., Wu, M., Wang, M., Sun, R., Jiang, Y., Guo, Q., Guo, D.-C., Liu, C.-Y., Chen, S., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.701745 · Cited by 58

Cardiac Remodeling After Myocardial Infarction: Functional Contribution of microRNAs to Inflammation and Fibrosis

Varzideh, F., Kansakar, U., Donkor, K., Wilson, S. M., Jankauskas, S. S., Mone, P., Wang, X., Lombardi, A., & Santulli, G. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.863238 · Cited by 58

BRD4 inhibition for the treatment of pathological organ fibrosis

Stratton, M. S., Haldar, S. M., & McKinsey, T. A. (2017) · F1000Research · doi:10.12688/f1000research.11339.1 · Cited by 58

Combined exposure of fine particulate matter and high-fat diet aggravate the cardiac fibrosis in C57BL/6J mice

Jiang, J., Li, Y., Liang, S., Sun, B., Shi, Y., Xu, Q., Zhang, J., Shen, H., Duan, J., & Sun, Z. (2020) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2020.122203 · Cited by 54

MiR-221-3p targets Hif-1α to inhibit angiogenesis in heart failure

Li, Y., Yan, C., Fan, J., Hou, Z., & Han, Y. (2020) · Laboratory Investigation · doi:10.1038/s41374-020-0450-3 · Cited by 57

Anti-oxidant and anti-inflammatory effects of ellagic and punicic acid in an in vitro model of cardiac fibrosis

Mannino, F., Imbesi, C., Bitto, A., Minutoli, L., Squadrito, F., D’Angelo, T., Booz, C., Pallio, G., & Irrera, N. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114666 · Cited by 60

Matrine attenuates cardiac fibrosis by affecting ATF6 signaling pathway in diabetic cardiomyopathy

Liu, Z., Zhang, Y., Tang, Z., Xu, J., Ma, M., Pan, S., Qiu, C., Guan, G., & Wang, J. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.03.061 · Cited by 57

MiR-101a loaded Extracellular Nanovesicles as Bioactive Carriers for Cardiac Repair

Wang, J., Lee, C. J., Deci, M. B., Jasiewicz, N. E., Verma, A., Canty, J. M., & Nguyen, J. (2020) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2020.102201 · Cited by 57

Hooked on heart regeneration: the zebrafish guide to recovery

Stewart, K. R., Walker, S. L. M., Baker, A. H., Riley, P. R., & Brittan, M. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab214 · Cited by 66

Mechanisms of Fibroblast Activation and Myocardial Fibrosis: Lessons Learned from FB-Specific Conditional Mouse Models

Umbarkar, P., Ejantkar, S., Tousif, S., & Lal, H. (2021) · Cells · doi:10.3390/cells10092412 · Cited by 58

Inhibition and inactivation of human CYP2J2: Implications in cardiac pathophysiology and opportunities in cancer therapy

Karkhanis, A. V., Hong, Y., & Chan, E. C. Y. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.02.017 · Cited by 56

Targeting Chondroitin Sulfate Glycosaminoglycans to Treat Cardiac Fibrosis in Pathological Remodeling

Zhao, R., Ackers-Johnson, M. A., Stenzig, J., Chen, C., Ding, T., Zhou, Y., Wang, P., Ng, S. L., Li, P. Y., Teo, G., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.030353 · Cited by 56

Targeting HMGB1 ameliorates cardiac fibrosis through restoring TLR2-mediated autophagy suppression in myocardial fibroblasts

Wu, R., Yu, T., Zhou, J., Li, M., Gao, H., Zhao, C., Dong, R., Peng, D., Hu, Z., Zhang, X., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.04.103 · Cited by 57

Raf kinase inhibitor protein mediates myocardial fibrosis under conditions of enhanced myocardial oxidative stress

Kazakov, A., Hall, R. A., Werner, C. M., Meier, T., Trouvain, A. M., Rodionycheva, S., Nickel, A. G., Lammert, F., Maack, C., Böhm, M., et al. (2018) · Basic Research in Cardiology · doi:10.1007/s00395-018-0700-3 · Cited by 55

68Ga-FAPI PET visualize heart failure: from mechanism to clinic

Song, W., Zhang, X., He, S., Gai, Y., Qin, C., Hu, F., Wang, Y., Wang, Z., Bai, P., Wang, J., et al. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-022-05994-4 · Cited by 56

Geniposide Alleviates Isoproterenol-Induced Cardiac Fibrosis Partially via SIRT1 Activation in vivo and in vitro

Li, N., Zhou, H., Ma, Z., Zhu, J., Liu, C., Song, P. K., Kong, C., Wu, H., Deng, W., & Tang, Q. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00854 · Cited by 55

Cardiac Fibrosis Is Associated With Decreased Circulating Levels of Full-Length CILP in Heart Failure

Park, S., Ranjbarvaziri, S., Zhao, P., & Ardehali, R. (2020) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2020.01.016 · Cited by 55

Hybrid Positron Emission Tomography/Magnetic Resonance Imaging in Arrhythmic Mitral Valve Prolapse

Miller, M. A., Adams, D. H., Pandis, D., Robson, P. M., Pawale, A. A., Pyzik, R., Liao, S. L., El‐Eshmawi, A., Boateng, P., Garg, J., et al. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.1555 · Cited by 55

Myofibroblast-Derived Exosome Induce Cardiac Endothelial Cell Dysfunction

Ranjan, P., Kumari, R., Goswami, S. K., Li, J., Pal, H. C., Suleiman, Z. G., Cheng, Z. A., Krishnamurthy, P., Kishore, R., & Verma, S. K. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.676267 · Cited by 54

Traditional Chinese medicine as a therapeutic option for cardiac fibrosis: Pharmacology and mechanisms

Li, X., Li, L., Lei, W., Chua, H. Z., Li, Z., Huang, X., Wang, Q., Li, N., & Zhang, H. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111979 · Cited by 55

Mitral Valve Prolapse Induces Regionalized Myocardial Fibrosis

Morningstar, J. E., Gensemer, C., Moore, R., Fulmer, D. B., Beck, T. C., Wang, C., Moore, K., Guo, L., Sieg, F., Nagata, Y., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.022332 · Cited by 57

Circular RNAs in cardiovascular diseases

Mei, X., & Chen, S. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107991 · Cited by 55

MicroRNA-24-3p alleviates cardiac fibrosis by suppressing cardiac fibroblasts mitophagy via downregulating PHB2

Zhang, Y., Wang, Z., Lan, D., Zhao, J., Wang, L., Shao, X., Wang, D., Wu, K., Sun, M., Huang, X., et al. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106124 · Cited by 53

Targeting EZH1 and EZH2 contributes to the suppression of fibrosis-associated genes by miR-214-3p in cardiac myofibroblasts

Zhu, W., Tang, C., Xiao, Z., Zhu, J.-N., Lin, Q., Fu, Y., Hu, Z.-Q., Zhang, Z., Yang, M., Zheng, X., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13048 · Cited by 53

Matrine suppresses cardiac fibrosis by inhibiting the TGF‑β/Smad pathway in experimental diabetic cardiomyopathy

Zhang, Y., Cui, L., Guan, G., Wang, J., Qiu, C., Yang, T., Guo, Y., & Liu, Z. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.8054 · Cited by 53

Topological Arrangement of Cardiac Fibroblasts Regulates Cellular Plasticity

Yu, J., Seldin, M. M., Fu, K., Li, S., Lam, L., Wang, P., Wang, Y., Huang, D., Nguyen, T. L., Wei, B., et al. (2018) · Circulation Research · doi:10.1161/circresaha.118.312589 · Cited by 53

Diverse origins and activation of fibroblasts in cardiac fibrosis

Aujla, P. K., & Kassiri, Z. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109869 · Cited by 55

Therapeutic Potential of Polyphenols in Cardiac Fibrosis

Zhang, N., Wei, W., Li, L., Hu, C., & Tang, Q. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00122 · Cited by 55

Delivery of a matrix metalloproteinase-responsive hydrogel releasing TIMP-3 after myocardial infarction: effects on left ventricular remodeling

Purcell, B. P., Barlow, S. C., Perreault, P. E., Freeburg, L., Doviak, H., Jacobs, J., Hoenes, A., Zellars, K. N., Khakoo, A. Y., Lee, T. W., et al. (2018) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00076.2018 · Cited by 52

ADAM17, A Key Player of Cardiac Inflammation and Fibrosis in Heart Failure Development During Chronic Catecholamine Stress

Adu‐Amankwaah, J., Adzika, G. K., Adekunle, A. O., Noah, M. L. N., Mprah, R., Bushi, A., Akhter, N., Huang, F., Xu, Y., Adzraku, S. Y., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.732952 · Cited by 53

Mechanism of action of non-coding RNAs and traditional Chinese medicine in myocardial fibrosis: Focus on the TGF-β/Smad signaling pathway

Li, C., Meng, X., Wang, L., & Dai, X. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1092148 · Cited by 57

Injectable decellularized extracellular matrix hydrogel loaded with exosomes encapsulating curcumin for prevention of cardiac fibrosis after myocardial infarction

Wang, Y., Wang, J., Liu, C., Li, J., Lu, K., Yu, Q., Zhang, Y., & Shen, Z. (2023) · Journal of Material Science and Technology · doi:10.1016/j.jmst.2023.06.005 · Cited by 51

Fibroblast growth factor-2, but not the adipose tissue-derived stromal cells secretome, inhibits TGF-β1-induced differentiation of human cardiac fibroblasts into myofibroblasts

Liguori, T. T. A., Liguori, G. R., Moreira, L. F. P., & Harmsen, M. C. (2018) · Scientific Reports · doi:10.1038/s41598-018-34747-3 · Cited by 51

Migratory and anti-fibrotic programmes define the regenerative potential of human cardiac progenitors

Poch, C. M., Foo, K. S., Angelis, M. T. D., Jennbacken, K., Santamaria, G., Bähr, A., Wang, Q., Reiter, F., Hornaschewitz, N., Zawada, D. M., et al. (2022) · Nature Cell Biology · doi:10.1038/s41556-022-00899-8 · Cited by 52

Fibroblast-Specific Proteotranscriptomes Reveal Distinct Fibrotic Signatures of Human Sinoatrial Node in Nonfailing and Failing Hearts

Kalyanasundaram, A., Li, N., Gardner, M. L., Artiga, E. J., Hansen, B. J., Webb, A., Freitas, M. A., Pietrzak, M., Whitson, B. A., Mokadam, N. A., et al. (2021) · Circulation · doi:10.1161/circulationaha.120.051583 · Cited by 51

The Combined Influence of Viscoelastic and Adhesive Cues on Fibroblast Spreading and Focal Adhesion Organization

Hui, E., Moretti, L., Barker, T. H., & Caliari, S. R. (2021) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-021-00672-1 · Cited by 49

Senescent cardiac fibroblasts: A key role in cardiac fibrosis

Osorio, J. M., Espinoza-Pérez, C., Rimassa-Taré, C., Machuca, V., Bustos, J. O., Vallejos, M., Vargas, H., & Dı́az-Araya, G. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166642 · Cited by 50

Resveratrol and beyond: The Effect of Natural Polyphenols on the Cardiovascular System: A Narrative Review

Gál, R., Halmosi, R., Gallyas, F., Tschida, M., Mutirangura, P., Tóth, K., Alexy, T., & Czopf, L. (2023) · Biomedicines · doi:10.3390/biomedicines11112888 · Cited by 58

Notch Signaling in Ischemic Damage and Fibrosis: Evidence and Clues from the Heart

Nistri, S., Sassoli, C., & Bani, D. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00187 · Cited by 50

BH3 mimetics as anti-fibrotic therapy: Unleashing the mitochondrial pathway of apoptosis in myofibroblasts

Kühl, T., & Lagares, D. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.01.020 · Cited by 49

Targeting fibrosis in the failing heart with nanoparticles

Passaro, F., Tocchetti, C. G., Spinetti, G., Paudice, F., Ambrosone, L., Costagliola, C., Cacciatore, F., Abete, P., & Testa, G. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.004 · Cited by 54

Exogenous spermine attenuates myocardial fibrosis in diabetic cardiomyopathy by inhibiting endoplasmic reticulum stress and the canonical Wnt signaling pathway

Hu, J. R., Lu, X., Zhang, X., Shao, X., Wang, Y., Chen, J., Zhao, B., Li, S., Xu, C., & Wei, C. (2020) · Cell Biology International · doi:10.1002/cbin.11360 · Cited by 49

Fibrosis in Pathology of Heart and Kidney: From Deep RNA-Sequencing to Novel Molecular Targets

Schreibing, F., Anslinger, T. M., & Kramann, R. (2023) · Circulation Research · doi:10.1161/circresaha.122.321761 · Cited by 51

Chronic activation of human cardiac fibroblasts in vitro attenuates the reversibility of the myofibroblast phenotype

Hall, C., Law, J. P., Reyat, J. S., Cumberland, M. J., Hang, S., Vo, N. T. N., Raniga, K., Weston, C. J., O’Shea, C., Townend, J., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-39369-y · Cited by 54

New Treatment Strategies for Alcohol-Induced Heart Damage

Fernández‐Solà, J., & Porta, A. P. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17101651 · Cited by 53

Developmental stage-dependent effects of cardiac fibroblasts on function of stem cell-derived engineered cardiac tissues

Liau, B., Jackman, C. P., Li, Y., & Bursac, N. (2017) · Scientific Reports · doi:10.1038/srep42290 · Cited by 49

Osteoglycin attenuates cardiac fibrosis by suppressing cardiac myofibroblast proliferation and migration through antagonizing lysophosphatidic acid 3/matrix metalloproteinase 2/epidermal growth factor receptor signalling

Zuo, C., Li, X., HUANG, J. C., Chen, D., Ji, K., Yang, Y., Xu, T., Zhu, D., Chen, Y., & Gao, P. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy035 · Cited by 49

Heart failure as interstitial cancer: emergence of a malignant fibroblast phenotype

Oatmen, K. E., Cull, E. H., & Spinale, F. G. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0286-y · Cited by 49

Unresolved Complexity in the Gene Regulatory Network Underlying EMT

Lavin, D. P., & Tiwari, V. K. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00554 · Cited by 50

The antihypertensive effect and mechanisms of bioactive peptides from Ruditapes philippinarum fermented with Bacillus natto in spontaneously hypertensive rats

Song, Y., Yu, J., Song, J., Wang, S., Cao, T., Liu, Z., Gao, X., & Wei, Y. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104411 · Cited by 49

Molecular Imaging of Inflammation and Fibrosis in Pressure Overload Heart Failure

Glasenapp, A., Derlin, K., Gutberlet, M., Hess, A., Roß, T. L., Wester, H., Bengel, F. M., & Thackeray, J. T. (2021) · Circulation Research · doi:10.1161/circresaha.120.318539 · Cited by 51

The Roles of lncRNA in Myocardial Infarction: Molecular Mechanisms, Diagnosis Biomarkers, and Therapeutic Perspectives

Xie, L., Zhang, Q., Mao, J., Zhang, J., & Li, L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.680713 · Cited by 50

Astragaloside IV Ameliorates Isoprenaline-Induced Cardiac Fibrosis in Mice via Modulating Gut Microbiota and Fecal Metabolites

Du, X., Shi, L., Chen, Z., Hu, J., Zuo, B., Xiong, Y., & Cao, W.-F. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.836150 · Cited by 47

Nrf2 Is a Key Regulator on Puerarin Preventing Cardiac Fibrosis and Upregulating Metabolic Enzymes UGT1A1 in Rats

Cai, S.-A., Hou, N., Zhao, G.-J., Liu, X.-W., He, Y., Liu, H., Hua, Y., Li, L., Huang, Y., Ou, C., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00540 · Cited by 48

Cardiac fibroblasts in myocardial injury and heart failure

Linthout, S. V., Matz, I., González, A., & Davis, J. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf902 · Cited by 38

Cardiac fibrosis: Pathobiology and therapeutic targets

Czubryt, M. P., & Hale, T. M. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2021.110066 · Cited by 74

Pathophysiology of cardiac fibroblasts and impacts on the severity of the cardiac disease

Duttaroy, A. K., & Mallick, R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99570-2.00016-3

Characteristics and Regulation of Cardiac Fibroblasts

Ying-bing, X. (2011) · Advances in Cardiovascular Diseases

The Janus face of myofibroblasts in the remodeling heart

Hermans, K. C. M., Daskalopoulos, E. P., & Blankesteijn, W. M. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.11.017 · Cited by 33